Euclid Transactional R&W/W&I Insurance February 2023 Update

Managing Principal Jay Rittberg highlighted January’s record-breaking numbers in a recent blog. Read more about Euclid Transactional’s success in his blog (linked here) or view the full text below. Euclid Transactional R&W/W&I Insurance February 2023 Update January was a record month at Euclid Transactional, […]

Read More

Q2 Update

While economic markers continue to produce mixed signals, M&A saw continued growth in Q2 relative to Q1 of 2022. Our results demonstrate continued strong demand for R&W with an increase in submissions and policies bound compared to the first quarter. A Look at Our […]

Read More

Keeping Pace…

The outlook for the M&A market appears murky for the second half of 2022, but the same cannot be said for RWI/W&I insurance claims. After record-breaking M&A volume from the end of 2020 through 2021, there are more RWI/W&I policies outstanding today than at any […]

Read More

War, Sanctions and Inflation: Reflections on the First Quarter

Russia’s invasion of Ukraine and the sweeping economic sanctions that followed have upended economic growth, oil prices, commodity markets – and, as a result, introduced uncertainty to 2022’s business outlook. In our market, we are watching developments closely and advising clients as they navigate […]

Read More

Q1 Update

Despite the horrible challenges created by the war in Ukraine and some uncertainty in the world of M&A, our 2022 first quarter results demonstrate a strong start to 2022 with submissions and policies bound exceeding 2021’s first quarter. A Look at Our Numbers While […]

Read More

Euclid Transactional R&W/W&I Insurance February 2022 Update

Although February saw uncertainty in the M&A industry and challenges created by the war in Ukraine, Euclid Transactional bound a record 83 R&W/W&I insurance policies worldwide, 6% more than February 2021. The average transaction value also increased to just over $450 million.

Read More

Thriving in Uncertain Times

This past year was marked by shifting narratives and unexpected outcomes.  The early optimism of new vaccines and a promising economic outlook was dampened by new coronavirus variants, supply chain constraints and pressure from inflation. Amidst this uncertain economic environment, M&A managed to post […]

Read More
The Impact of Covid-19 on R&W/W&I – Euclid Transactional October 2020 Update

The Impact of Covid-19 on R&W/W&I – Euclid Transactional October 2020 Update

Continuing with our monthly updates on how Covid-19 is changing the landscape for M&A, below are Euclid Transactional’s stats through September on global R&W/W&I insurance submissions and policies bound for 2020. Consistent with articles like this one in the Financial Times describing the summer of 2020 as […]

Read More
The Impact of Covid-19 on R&W/W&I – Euclid Transactional September 2020 Update

The Impact of Covid-19 on R&W/W&I – Euclid Transactional September 2020 Update

Continuing with our monthly updates on how Covid-19 is changing the landscape for M&A, below are Euclid Transactional’s stats through August on global R&W/W&I insurance submissions and policies bound for 2020. In August, policy submissions increased, finally returning to 2019 levels after dropping around 70% […]

Read More
The Impact of Covid-19 on R&W/W&I – Euclid Transactional May 2020 Update

The Impact of Covid-19 on R&W/W&I – Euclid Transactional May 2020 Update

With Covid-19 drastically changing the landscape for M&A, you may find Euclid Transactional’s data on R&W/W&I insurance helpful. Below are our stats on global R&W/W&I insurance submissions and policies bound for 2020. Among other things, weekly submissions dropped by over 70%, average deal size decreased considerably […]

Read More